Morphine and ketamine inhibit immune function of gastric cancer patients by increasing percentage of CD4+CD25+Foxp3+ regulatory T cells in vitro
详细信息    查看全文
文摘
There is conflicting evidence regarding effects of anesthetic and analgesic drugs on immune function of cancer patients. This study was designed to observe changes of T cell subpopulations in the gastric cancer (GC) patients and to assess effects of morphine and ketamine on the CD4+ T cells, CD8+ T cells, and regulatory T cells (Tregs) populations obtained from the GC patients in vitro.

Methods

The peripheral blood samples from 20 GC patients and 20 healthy volunteers were obtained. The peripheral blood mononuclear cells were isolated and incubated in a solution containing phorbol-myristate-acetate and ionomycin (2 μL/mL) in the presence or absence of morphine (50 ng/mL) or different-concentration ketamine (25, 50, and 100 μM). The CD4+ T cells, CD8+ T cells, and Tregs were determined using the flow cytometric assay.

Results

The percentages of CD8+ T cells were significantly decreased, but the ratio of CD4+/CD8+ T cells and Tregs populations was significantly increased in the GC control group compared with the normal control group (P < 0.05). The ratio of CD4+/CD8+ T cells was significantly increased in the groups M and K3 compared with the control group (P < 0.05) but was significantly decreased in the group K1 compared with the group K3. The percentage of Tregs was significantly increased in the groups M, K1, K2, and K3 compared with the control group. With the increased concentrations, ketamine increased the number of Tregs.

Conclusions

GC shifts the balance of CD4+/CD8+ T cells toward CD4+ T cells and increases the Tregs populations by inducing immune responses. Morphine increases the ratio of CD4+/CD8+ T cells and Tregs populations. Ketamine affects the ratio of CD4+/CD8+ T cells and Tregs populations in a dose-dependent model.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700